India Bladder Cancer Market is Expected to grow at a CAGR of 9.9% During Forecast 2020-2026
India bladder cancer market is estimated to grow modestly at a CAGR of around 9.9% during the forecast period. The market growth attribited to the prevalence of smoking among adults and elders, various type of cancer is being diagnosed in the country. With the increasing population affected by smoking, bladder cancer cases are estimated to grow multi-fold in the country. The number of bladder cancer patients is directly proportional to the increasing population of the country, which as a result is supposed to augment the growth of the bladder cancer market in India during the forecast period.
India is one of the fastest emerging economies across the
globe and with the growth in the economy, the healthcare sector is developing
with a considerable rate in the country. The increasing number of diseases is
one of the major factors contributing to the development of the healthcare
system of the country. According to IBEF (India Brand Equity Foundation),
India’s healthcare industry has reached $160 billion in 2017 and is estimated
to grow at the CAGR of 16.3% till 2022. The industry is estimated to reach $372
billion in 2022. With the growing healthcare industry of the country, the
bladder cancer market in the country is estimated to increase with a
significant rate during the forecast period.
To
Request a Sample of our Report on India
Bladder Cancer Market:
https://www.omrglobal.com/request-sample/india-bladder-cancer-market
India bladder cancer market is segmented into cancer type,
diagnosis, and treatment. Based on cancer type, the market is segmented into
transitional cell bladder cancer/ urothelial carcinoma, squamous cell bladder
cancer, adenocarcinoma, and other rare types (sarcomas, carcinoma in situ).
Based on the diagnosis, the market is segmented into cystoscopy, biopsy,
urinalysis, urine cytology, intravenous pyelogram (IVP), and others. Based on
treatment, the market is segmented into chemotherapy, immunotherapy, radiation
therapy, surgery, and other treatment which include targeted therapy.
(Get 15% Discount on Buying this Report)
A full
Report of India Bladder Cancer Market is Available at: https://www.omrglobal.com/industry-reports/india-bladder-cancer-market
India Bladder Cancer Market Segmentation
By Cancer Type
·
Transitional Cell Bladder Cancer/ Urothelial
Carcinoma
·
Squamous Cell Bladder Cancer
·
Adenocarcinoma
·
Others (Sarcomas, Carcinoma in Situ)
By Diagnosis
·
Cystoscopy
·
Biopsy
·
Urinalysis
·
Urine Cytology
·
Intravenous Pyelogram (IVP)
·
Others (Biomarkers)
By Treatment
·
Surgery
·
Chemotherapy
·
Immunotherapy
·
Radiation Therapy
·
Others (Targeted Therapy)
Company
Profiles
·
Astellas Pharma Inc.
·
AstraZeneca PLC
·
Bayer AG
·
Bristol-Myers Squibb Co.
·
Eli Lilly and Co.
·
F. Hoffmann-La Roche AG
·
GlaxoSmithKline Plc
·
Johnson & Johnson Services, Inc.
·
Merck KGaA
·
Pfizer Inc.
·
Sysmex Corp.
Reasons
to buy from us –
1.
We cover more than 15 major industries, further segmented into more than 90
sectors.
2.
More than 120 countries are for analysis.
3.
Over 100+ paid data sources mined for investigation.
4.
Our expert research analysts answer all your questions before and after
purchasing your report.
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
Media Contact:
Company Name: Orion
Market Research
Contact Person: Mr.
Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment